Skip to main content
Clinical Trials/NCT03089255
NCT03089255
Completed
Not Applicable

Prospective Study to Assess the Foreseeable Impact of TIP Score on Thromboprophylaxis in Patients With Isolated Non-surgical Lower Limb Trauma Compared to the Physicians' Judgment in Standard Practice.

University Hospital, Angers1 site in 1 country196 target enrollmentApril 3, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lower Limb Injury
Sponsor
University Hospital, Angers
Enrollment
196
Locations
1
Primary Endpoint
Rate of prescriptions of prophylactic anticoagulation if TIP score was applied compared to the physicians' judgment in standard practice.
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Traumatic lesions are the leading causes of admission to the emergency center (39%), isolated non-surgical lower limbs trauma are in the foreground. Two recent meta-analyzes suggest the value of Low Molecular Weight Heparins (LMWH) which would reduce symptomatic Thromboembolism Events (TE) in patients with lower limb trauma. However, many recent studies conclude to the need of stratifying the TE risk according to the patient and the nature of his trauma to obtain an individualized therapeutic decision.

The retrospectively established L-TRIP (cast) score allows stratification of the risk without taking into account the type of trauma. The TIP score (Trauma, Immobilization and Patient) was established by consensus of international experts via the Delphi method.

We suggest that the application of the TIP score to rationalize indications of thromboprophylaxis in patients with isolated non-surgical trauma of a lower limb should reduce the rate of anticoagulation prescription without increasing the risk of symptomatic thromboembolic complications with a direct benefit for patients and medico-economic for the society.

Detailed Description

All patients admitted to the Emergency Departments for a nonsurgical isolated lower limb trauma necessitating rigid or semi-rigid immobilization, will be assessed for possible participation. After the physicians had obtained the no-opposition of the patient, they will fill a questionnaire. This questionnaire includes the treatment chosen by the physician, the type of trauma, the type of immobilization chosen, and the patient's thromboembolic risk factors in order to calculate the TIP and L-TRIP (cast) scores retrospectively. Phone follow-up will occur within 3 months to gather clinical event data (any signs of VTE, any bleeding events).

Registry
clinicaltrials.gov
Start Date
April 3, 2017
End Date
January 30, 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Angers
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Consultation in one of the emergency departments of the participating centres
  • Isolated unilateral lower limb injury not requiring surgery
  • Lower limb rigid or semi-rigid orthopedic immobilization (i.e. brace of plaster cast) for at least 5 days.
  • Full insurance cover

Exclusion Criteria

  • Any anticoagulant or antiplatelet treatment prior to trauma
  • Contra-indication to fondaparinux or LMWH
  • Factors rendering 3-month follow-up impossible
  • Imprisonment
  • Inability to provide informed consent

Outcomes

Primary Outcomes

Rate of prescriptions of prophylactic anticoagulation if TIP score was applied compared to the physicians' judgment in standard practice.

Time Frame: one day

Compare two rate (percent) of prescription: obtained with standard practice and with the foreseeable TIP score calculated retrospectively. Score TIP is calculated retrospectively based on datas of the patients included. A threshold value is established by an expert consensus. A score is positive if it is higher than the threshold value, and negative if it is lower or equal to the threshold value. We consider that patients with a negative score would not have been treated by a prophylactic anticoagulation if the TIP score was applied.

Secondary Outcomes

  • The cumulative rate of symptomatic venous thromboembolism (i.e. deep venous thrombosis and/or pulmonary embolism) at 3 months from inclusion.(3 months)
  • The 3-month rate of major bleeding and of non-major clinically relevant bleeding according to the ISTH definition.(3 months)
  • Rate of prescriptions of prophylactic anticoagulation if L-TRIP(cast) score was applied compared to the physicians' judgment in standard practice.(one day)

Study Sites (1)

Loading locations...

Similar Trials